Patent · US Active

Long-acting GLP-1r agonist as a therapy of neurological and neurodegenerative conditions

US12233109B2 · kind B2 · utility

0Cited by

2References

32Claims

0Family size

Assignee

THE JOHNS HOPKINS UNIVERSITY · US

Inventors

Seulki Lee · Elkridge, US
Ted M. Dawson · Baltimore, US
Han Seok Ko · Baltimore, US
Valina L. Dawson · Baltimore, US
Seung Pil Yun · Timonium, US
Magdalena Scully · Columbia, US

Key dates

Filing date	Sep 20, 2021
Grant date	Feb 25, 2025
Priority date	—
Expiry date	Sep 20, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/28
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compositions and methods for treating neurodegenerative conditions using GLP-1r agonists. In certain embodiments, long-acting GLP-1r agonists have neuroprotective and disease modifying effects on the central nervous system.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.